YOLFTbeta
Provexis plc

Provexis plc

PXS · LSE · Healthcare / Drug Manufacturers - Specialty & Generic

0.805GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.805
Open0.9362
Day Range0.71 – 0.9362
52-Week Range0.55 – 1.55
Volume1.01M
Market Cap22.29M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.68
50-Day Avg1.07
200-Day Avg1.10

About

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. It provides syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. The company also provides Fruitflow+ Omega-3, a dietary supplement product. It sells its products through e-commerce website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Ian Ford BA (Hons) ACA, F.C.A.
  • Employees2
  • Headquarters2 Blagrave Street, Reading, United Kingdom, RG1 1AZ, UK
  • Websitehttps://www.provexis.com

Leadership

  • Mr. Ian Ford BA (Hons) ACA, F.C.A.CEO, CFO, Company Secretary & Executive Director · b. 1965
  • Dr. Niamh Ann O'Kennedy B.Sc., M.Sc., Ph.D.Chief Scientific Officer, Member of Scientific Advisory Board & Executive Director · b. 1973
  • Prof. Asim K. Duttaroy BS MS Ph.D., DSc FICNConsultant & Member of Scientific Advisory Board

Financials

Income Statement

Currency: GBP2004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312023-09-302024-03-312025-03-312026-03-31
Total Revenue75.00K310.00K268.00K67.00K162.00K5.00K15.00K50.00K3.48M5.56M3.97K38.22K91.65K227.62K235.80K322.19K347.94K505.33K426.17K389.92K598.08K801.96K1.29M1.26M
Growth (%)-+313.33%-13.55%-75.00%+141.79%-96.91%+200.00%+233.33%+6856.00%+59.85%-99.93%+863.55%+139.77%+148.36%+3.60%+36.63%+7.99%+45.24%-15.67%-8.51%+53.39%+34.09%+61.13%-2.14%
Cost of Revenue52.00K470.00K176.00K-----1.72M2.42M0009.53K23.17K49.43K35.78K49.14K46.12K95.50K318.64K518.17K759.30K753.64K
Gross Profit23.00K-160.00K92.00K67.00K162.00K5.00K15.00K50.00K1.76M3.14M3.97K38.22K91.65K218.09K212.64K272.76K312.15K456.19K380.05K294.42K279.44K283.80K532.94K510.89K
Gross Margin30.67%-51.61%34.33%100.00%100.00%100.00%100.00%100.00%50.55%56.50%100.00%100.00%100.00%95.81%90.18%84.66%89.72%90.28%89.18%75.51%46.72%35.39%41.24%40.40%
Operating Expense883.00K947.00K264.00K1.56M1.37M4.68M1.80M2.52M6.09M7.80M1.02M536.46K547.13K630.06K680.56K806.66K736.97K815.65K679.25K715.35K776.03K887.39K981.26K1.00M
Operating Income-860.00K-1.11M-172.00K-1.49M-1.21M-4.68M-1.79M-2.48M-4.33M-4.66M-1.02M-498.24K-455.48K-411.98K-467.93K-533.90K-424.81K-359.46K-299.20K-420.93K-496.59K-603.59K-448.32K-491.94K
Operating Margin-1146.67%-357.10%-64.18%-2222.39%-745.68%-93520.00%-11920.00%-4950.00%-124.50%-83.76%-25686.31%-1303.47%-496.98%-180.99%-198.44%-165.71%-122.09%-71.13%-70.21%-107.95%-83.03%-75.26%-34.69%-38.90%
EBITDA-849.53K-1.80M-3.09M-1.46M-1.14M-4.59M-1.77M-2.31M-2.80M-1.45M-1.01M-489.10K57.89K31.89K19.82K-513.03K-403.94K-359.46K-283.08K-420.93K--603.59K-449.63K-491.94K
EBITDA Margin-1132.71%-579.35%-1153.63%-2174.63%-701.23%-91800.00%-11780.00%-4626.37%-80.60%-26.07%-25455.91%-1279.55%63.16%14.01%8.40%-159.23%-116.10%-71.13%-66.42%-107.95%--75.26%-34.79%-38.90%
Net Income-855.00K-1.09M-49.00K-2.44M-1.19M-4.57M-1.65M-1.98M-3.87M-4.34M488.35K-435.60K-409.57K-380.09K-448.11K-513.03K-406.23K-341.01K-224.25K-385.24K-496.59K-586.24K-452.72K-502.76K
Net Income Margin-1140.00%-352.26%-18.28%-3638.81%-733.95%-91420.00%-10986.67%-3968.00%-111.36%-78.04%12310.39%-1139.59%-446.89%-166.98%-190.03%-159.23%-116.75%-67.48%-52.62%-98.80%-83.03%-73.10%-35.03%-39.76%
R&D--394.00K340.00K517.00K635.00K698.00K1.25M761.00K475.55K142.99K180.50K192.24K187.16K181.92K229.88K251.87K303.90K249.69K237.22K270.05K301.72K325.63K235.63K
R&D as % of Total Revenue--147.01%507.46%319.14%12700.00%4653.33%2502.00%21.88%8.55%3604.36%472.21%209.75%82.23%77.15%71.35%72.39%60.14%58.59%60.84%45.15%37.62%25.20%18.63%
Interest Expense1.00K20.00K6.00K90.00K1.00K10.00K037.00K42.00K3.27K000000007373----
Interest Expense % of Total Revenue1.33%6.45%2.24%134.33%0.62%200.00%0.00%74.00%1.21%0.06%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.02%0.02%----

Balance Sheet

Currency: GBP2004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets323.00K1.45M9.66M7.45M7.95M5.77M11.36M12.04M13.41M10.37M643.29K359.98K256.58K158.20K418.64K462.03K468.76K1.29M1.13M845.99K498.04K1.01M1.30M
Total Liabilities215.00K943.00K807.00K839.00K361.00K234.00K295.00K564.00K2.12M2.47M108.21K114.08K113.75K133.31K89.38K123.14K150.08K150.68K157.91K188.34K307.45K248.21K722.92K
Total Equity108.00K510.00K8.86M6.63M7.58M5.53M11.06M11.62M11.52M8.18M858.55K621.53K549.63K462.67K786.37K816.34K814.37K1.66M1.50M1.19M724.34K1.30M1.11M
Cash187.00K1.11M2.17M116.00K532.00K1.68M7.05M7.55M1.45M616.61K514.83K285.40K189.64K12.35K315.17K325.64K291.33K1.08M863.87K379.12K189.36K708.09K893.14K
Total Debt215.00K400.00K-100.00K-----226.65K-------------
Net Debt28.00K-706.00K-2.17M-16.00K-532.00K-1.68M-7.05M-7.55M-1.45M-389.97K-514.83K-285.40K-189.64K-12.35K-315.17K-325.64K-291.33K-1.08M-863.87K-379.12K-189.36K-708.09K-893.14K

Cash Flow

Currency: GBP2004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312023-09-302024-03-312025-03-31
Operating Cash Flow-763.00K-1.26M-2.75M-2.18M-1.49M-1.35M-1.50M-2.05M-2.17M-1.43M-573.34K-404.78K-366.10K-430.30K-363.05K-384.01K-334.64K-262.07K-213.54K-519.85K-427.60K-191.50K-340.83K
Investing Cash Flow-15.00K24.00K871.00K29.00K-40.00K32.00K34.00K73.00K-7.25M-442.24K-108.84K4.95K2.93K4.01K374490399-25078887-1.73K1.93K
Financing Cash Flow921.00K2.16M2.94M100.00K1.94M2.46M6.84M2.48M3.31M1.04M278.70K170.40K267.40K249.00K665.50K394.00K300.33K1.05M1.05M35.10K--857.63K
Capital Expenditure15.00K2.00K16.00K098.00K30.00K36.00K75.00K521.00K454.66K00000002502500000
Free Cash Flow-778.00K-1.27M-2.77M-2.18M-1.58M-1.38M-1.54M-2.13M-2.69M-1.89M-573.34K-404.78K-366.10K-430.30K-363.05K-384.01K-334.64K-262.32K-213.79K-519.85K-427.60K-191.50K-338.90K
FCF to OCF101.97%100.16%100.58%100.00%106.59%102.22%102.40%103.65%124.05%131.72%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.10%100.12%100.00%100.00%100.00%99.43%

Key Statistics & Ratios

Market Cap22.29M
Enterprise Value23.05M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales17.62
Price / Book20.60
EPS0.00
Book Value0.00
Revenue (TTM)1.26M
Gross Profit (TTM)510.89K
Profit Margin-39.76%
Operating Margin-22.42%
Return on Equity-75.26%
Return on Assets-27.72%
Shares Outstanding2.35B
Shares Float1.81B
Beta0.68
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 23, 20052:1